Skip to main content
. 2010 Jun 29;8(6):e1000408. doi: 10.1371/journal.pbio.1000408

Table 1. Summary of phenotypic data of the candidate genes implicated in HR-DSBR.

Gene Name Ensembl ID Frequency of HR-DSBR GFP Levels Viability Increased Sensitivity Gamma-H2AX Assay
esiRNA 1 esiRNA 2 Cisplatin MMC IR
ACTB ENSG00000075624 ↓↓
AIP ENSG00000110711 ++
ALOX15 ENSG00000161905 ↓↓ ↓↓ + ++
ARHGEF1 ENSG00000076928 ↓↓ ↓↓ + + ↓ 1h, ↓ 6h
BCAM ENSG00000187244 ↓↓ ↓↓ + +
BRCA1 ENSG00000012048 ↓↓↓ ↓↓↓ + + +++ + ↑ 6h
C1orf63 ENSG00000117616 ↓↓ ↓↓ + + + ↑ 6h
CHCHD2 ENSG00000106153 ↓↓ ↓↓ + ++
DRG2 ENSG00000108591 ↓↓ ↓↓ +++
ETFB ENSG00000105379 ↓↓ ↓↓ + ++
FAM110C ENSG00000184731 ↓↓ +
FIZ1 ENSG00000179943 ↓↓ + ↓ 6h
GAK ENSG00000178950 ↓↓ ↓↓ +
HNRPA0 ENSG00000177733 ↓↓ ↓↓ + ↓ 6h
IGLON5 ENSG00000142549 ↓↓ ↓↓ +
KIAA0415 ENSG00000164917 ↓↓ ↓↓ ++
NTHL1 ENSG00000065057 ↓↓ ↓↓ +++ ↑ 6h
OSBPL5 ENSG00000021762 ↓↓ + ++
PRPF40B ENSG00000110844 ↓↓ ↓↓ ++ ↑ 6h
PSMD4 ENSG00000159352 ↓↓ ↓↓↓ + +
RAD51 ENSG00000051180 ↓↓↓ ↓↓↓ + +++ +++ ++ ↑ 6h
RBBP8 ENSG00000101773 ↓↓ ↓↓ ++ + ↑ 6h
RBM42 ENSG00000126254 ↓↓ ↓↓ ++
RECQL4 ENSG00000160957 ↓↓ ++ +
SEMA7A ENSG00000138623 ↓↓ ↓↓ +
SERPINH1 ENSG00000149257 ↓↓ +
SHFM1 ENSG00000127922 ↓↓↓ n.a. ++ +++
TRMT2A ENSG00000099899 ↓↓ + + ↑ 6h
TSKU ENSG00000182704 ↓↓ +
XPC ENSG00000154767 ↓↓ ↓↓ + ++
ZMYND15 ENSG00000141497 ↓↓ +++
ARCN1 ENSG00000095139 ↓↓ ++ n.d n.d n.d n.d
CKAP5 ENSG00000175216 ↓↓ ↓↓ ++ n.d n.d n.d n.d
CWC22 ENSG00000163510 ↓↓↓ ↓↓ ++ n.d n.d n.d n.d
DDB1 ENSG00000167986 ↓↓ ↓↓ ++ n.d n.d n.d n.d
E2F1 ENSG00000101412 ↓↓ ++ n.d n.d n.d n.d
HNRPK ENSG00000165119 ↓↓ ↓↓ ++ n.d n.d n.d n.d
PSMD1 ENSG00000173692 ↓↓↓ ↓↓↓ ++ n.d n.d n.d n.d
PSMD14 ENSG00000115233 ↓↓ ↓↓↓ ++ n.d n.d n.d n.d
SNRNP200 ENSG00000144028 ↓↓ ↓↓↓ ++ n.d n.d n.d n.d
THOC4 ENSG00000183684 ↓↓ ↓↓ ++ n.d n.d n.d n.d
TPX2 ENSG00000088325 ↓↓ ↓↓↓ ++ n.d n.d n.d n.d
VPRBP ENSG00000145041 ↓↓↓ ↓↓ ++ n.d n.d n.d n.d
ZYG11BL ENSG00000160445 ↓↓ ++ n.d n.d n.d n.d
MKNK2 ENSG00000099875 ↓↓ ↓↓ + n.d n.d n.d n.d
ATXN3 ENSG00000066427 ↑↑ ↑↑ n.d n.d n.d n.d
C5orf28 ENSG00000151881 ↑↑ ↑↑ n.d n.d n.d n.d
C6 ENSG00000039537 ↑↑ ↑↑ n.d n.d n.d n.d
CNGA1 ENSG00000198515 ↑↑ ↑↑ n.d n.d n.d n.d
CREBBP ENSG00000005339 ↑↑↑ n.d n.d n.d n.d
DNAJB4 ENSG00000162616 ↑↑ ↑↑ n.d n.d n.d n.d
LIG4 ENSG00000174405 ↑↑ ↑↑ n.d n.d n.d n.d
LYRM7 ENSG00000186687 ↑↑ ↑↑ n.d n.d n.d n.d
MMRN1 ENSG00000138722 ↑↑ ↑↑ n.d n.d n.d n.d
PDHX ENSG00000110435 ↑↑ ↑↑ n.d n.d n.d n.d
SLC39A12 ENSG00000148482 ↑↑ n.d n.d n.d n.d
SMCHD1 ENSG00000101596 ↑↑↑ ↑↑ n.d n.d n.d n.d
SMS ENSG00000102172 ↑↑ ↑↑ n.d n.d n.d n.d
STAG2 ENSG00000101972 ↑↑ ↑↑ n.d n.d n.d n.d
USP12 ENSG00000152484 ↑↑↑ ↑↑ n.d n.d n.d n.d
WRB ENSG00000182093 ↑↑ ↑↑ n.d n.d n.d n.d
XRCC2 ENSG00000196584 ↑↑ ↑↑ n.d n.d n.d n.d

Calculated z-scores using esiRNA against Rluc as negative controls are shown for two independent esiRNA and marked with arrows. Genes that after knockdown decreased the frequency of HR below z-score −4, −2, or −1.5 are marked with ↓↓↓, ↓↓ or ↓, respectively; genes that increase the frequency of HR over z-score 4, 2, or 1.5 are marked with ↑↑↑, ↑↑, or ↑, respectively; n.a., not available. Genes that decreased GFP levels with a z-score>4 are marked with +. Genes that after knockdown decreased viability below 50% and 25% are marked with ++ and +, respectively. Genes that after knockdown decrease the cell number when treated with cisplatin, MMC, or IR by 40%, 30%, or 10% in comparison to Rluc transfection are marked with +++, ++, and +, respectively; n.d., not done. In the last column arrows indicate ↑ increased and decreased ↓ number of gamma-H2AX positive cells after 1 h or 6 h post-IR for knockdowns statistically different (p<0.05) from Rluc transfections.